Market closedNon-fractional

Immuneering/IMRX

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX

About Immuneering

Immuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug development process. The company's proprietary computational Disease Cancelling Technology platform enables Immuneering's drug discovery programs. The company also provides unparalleled computational biology capabilities to pharmaceutical and biotechnology companies.

Ticker

IMRX

Sector

Healthcare

Trading on

NASDAQ

Industry

Biotechnology

Headquarters

Cambridge, United States

Employees

65

Immuneering Metrics

BasicAdvanced
$32M
Market cap
-
P/E ratio
-$1.86
EPS
-0.60
Beta
-
Dividend rate
$32M
-0.6
14.379
13.767
5.186
5.565
-37.73%
-61.38%
0.41
0.45
-0.63
-4.18%
-22.89%

What the Analysts think about Immuneering

Analyst Ratings

Majority rating from 8 analysts.
Buy

Immuneering Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
0.00% profit margin
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$0
NaN%
Net income
-$14M
-4.67%
Profit margin
0.00%
NaN%

Immuneering Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 2.56%
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
-$0.43
-$0.43
-$0.52
-$0.49
-
Expected
-$0.53
-$0.49
-$0.47
-$0.50
-$0.52
Surprise
-18.48%
-12.91%
11.27%
-2.56%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Immuneering stock?

Immuneering (IMRX) has a market cap of $32M as of July 06, 2024.

What is the P/E ratio for Immuneering stock?

The price to earnings (P/E) ratio for Immuneering (IMRX) stock is 0 as of July 06, 2024.

Does Immuneering stock pay dividends?

No, Immuneering (IMRX) stock does not pay dividends to its shareholders as of July 06, 2024.

When is the next Immuneering dividend payment date?

Immuneering (IMRX) stock does not pay dividends to its shareholders.

What is the beta indicator for Immuneering?

Immuneering (IMRX) has a beta rating of -0.6. This means that it has an inverse relation to market volatility.

Buy or sell Immuneering stock

Buy or sell Immuneering stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing